Physician profile
Sanjay Tomar
NPI 1215106836
$660.85
in general payments reported to CMS, 2019-2025
20 companies · $99.55 in 2025
The $99.55 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.63 · 2020: $36.28 · 2022: $179 · 2023: $217 · 2024: $56.85 · 2025: $99.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $198 · Consulting Fee: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.42 |
| Consulting Fee | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $175.00 | 2023 | Recell |
| Novo Nordisk INC | $114.04 | 2019-2022 | |
| Abbvie INC. | $52.41 | 2022 | |
| Ucb, INC. | $27.23 | 2025 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $23.52 | 2023 | Ilumya |
| Arcutis Biotherapeutics, INC. | $23.13 | 2024 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $22.42 | 2022 | |
| Vyne Pharmaceuticals INC. | $21.98 | 2020 | |
| Cequr Corporation | $19.50 | 2025 | Cequr Simplicity |
| Pfizer INC. | $18.65 | 2024 | |
| Botanix Sb INC | $18.56 | 2025 | Sofdra |
| Mylan Institutional INC. | $18.50 | 2023 | |
| Lnhc, INC | $18.37 | 2025 | Zelsuvmi |
| Taro Pharmaceuticals USA, INC. | $18.26 | 2019 | |
| Leo Pharma INC. | $16.84 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $15.89 | 2025 | Nemluvio |
| Lilly USA, LLC | $15.07 | 2024 | Ebglyss, Taltz |
| Strata Skin Sciences, INC. | $14.30 | 2020 | |
| Melinta Therapeutics, LLC | $13.69 | 2019 | |
| Solta Medical, A Division of Bausch Health US, LLC | $13.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Tomar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.